Need to file an Actos lawsuit? Contact Williams Kherkher today at 800-641-9810.

Researchers find link between vitamin D and bladder cancer

Posted on November 2nd, 2012 No Comments

Researchers from Spain’s National Cancer Research Center have discovered what they believe to be a relationship between bladder cancer and vitamin D. Their research indicates that high levels of vitamin D can lead to a decreased risk of bladder cancer while a deficiency in the vitamin can actually increase a person’ s risk of the […]

Tagged , , | Leave a comment

Consumer Reports urges consumers to avoid Actos

Posted on September 10th, 2012 No Comments

Days after the Food and Drug Administration’s (FDA) approval of a generic version of Actos (pioglitazone), consumer advocacy group Consumer Reports released a statement claiming that the risks of using pioglitazone far outweigh its benefits. The group asks customers to avoid Actos and its generics unless other treatments have failed them, citing the drug’s dangerous […]

Tagged , , | Leave a comment

First federal Actos trial to be held in 2014

Posted on August 6th, 2012 No Comments

The first federal trial for people who have developed bladder cancer as a result of taking Actos is scheduled for November of 2014. The trial is set to start so far in the future in part due to the sheer number of suits, and in part to give attorneys time to choose the best cases […]

Tagged , , | Leave a comment

New study corroborates link between Actos and bladder cancer

Posted on July 6th, 2012 No Comments

A new Canadian study agrees with the well-established link between Actos and bladder cancer. The study, published in the Canadian Medical Association Journal, was conducted via meta-analysis, meaning it sought patterns in data compiled by numerous other studies. The study examined the relationship between diabetes medications known as thiazolidinediones and bladder cancer. It explored data […]

Tagged , , | Leave a comment

Actos lawsuit filed in New York

Posted on June 19th, 2012 No Comments

A new Actos lawsuit has been filed in a district court in New York. The lawsuit adds to the great deal of claims surfacing in the wake of the now-established link between Actos and its serious side effects. Actos has been shown to increase a patient’s risk of bladder cancer by more than 80%. This […]

Tagged , , | Leave a comment

Diabetics on weight loss show stopped needing meds after losing weight

Posted on May 31st, 2012 No Comments

Diabetic contestants on weight loss television program “The Biggest Loser” found that after losing weight, they stopped needing their diabetes medication. After a few weeks of intense exercise, one contestant went from taking six daily insulin injections and several prescription medications to not needing any of it. The show’s medical adviser found that all indications […]

Tagged , , | Leave a comment

Takeda Pharmaceutical prepares for Actos patent to expire

Posted on May 16th, 2012 No Comments

As Takeda Pharmaceutical’s patent on Actos gets closer to its August expiration, the company is making efforts to offset the decreased profits it will lose to generic versions of the drug. The company expects to miss out on over $2 billion in revenue to generic versions of its flagship drug. Takeda has been preparing for […]

Tagged , , | Leave a comment

Actos replacement denied by FDA

Posted on May 1st, 2012 No Comments

While Actos is being plagued by its link to numerous life-threatening ailments, its heir may be facing guilt by association. Takeda Pharmaceutical’s patent on pioglitazone (the active ingredient in Actos) is due to run out this August. The company will soon be facing competition from generic pioglitazone manufacturers. Because of this, the company is hoping […]

Tagged , , | Leave a comment

Type 2 diabetes prevention

Posted on February 20th, 2012 No Comments

Nearly 23. 6 million people suffer from Type 2 diabetes and the number is continuing to grow. According to data from the National Institutes of Health, nearly 6 million of the people that have the disease have not been diagnosed with it at this time. Type 2 diabetes occurs when a person’s body is unable […]

Tagged , | Leave a comment

Judge schedules first Actos hearing

Posted on February 16th, 2012 No Comments

A judge in Louisiana has now scheduled the first hearing against the makers of the Type 2 diabetes medication, Actos. The initial court hearing is for the group of lawsuits that claim that the use of Actos caused an increased risk of bladder cancer. Plaintiffs are expected to file thousands of lawsuits against the pharmaceutical […]

Tagged , , | Leave a comment
Contact Williams Kherkher

By submitting this form, you certify that you agree to our terms and conditions and wish to be contacted regarding your inquiry.

home  |  about us  |  attorneys  |  actos  |  bladder cancer  |  faqs  |  articles  |  law resources  |  press release  |  contact us  |  blog  |  Log in
Copyright ©2007-2010 Williams Kherkher. Attorneys are licensed only in the state of Texas unless otherwise indicated in the biographical section. Past performance is no guarantee of future results. Williams Kherkher's primary office is located in Texas. Terms of Use. Disclaimer. Sitemap.
8441 Gulf Freeway, Suite 600, Houston, TX 77017-5051 -- 800-641-9810 | John Eddie Williams +